| News |
| FISIOLINE has obtained the FDA approval in September 2006 for its laser LUMIX 2 |
Concluded with very good results the experimentation on the bone regrowth in dental field with the superpulsed laser FISIOLINE.
The bone regrowth on the osteoblasts has been demonstrated by the team of the Prof. Canuto at the Medicine & Oncology Experimental Department of the University of Turin. |
| Fisioline has obtained the FDA approval in November 2004 for its laser devices. |
Great public success at the Fisioline stand at Exposanità 2006 on the occasion of the LUMIX3 presentation, the first laser with the exclusive C.P.S. technology. An innovative laser piloting allows the emission, on a single spot, of three types of different laser diodes: Continuous, Pulsed and Superpulsed for a versatility without equals. |
Fisioline reaches a great scientific target at the San Pablo C.E.U. university of Madrid.
The professor José Vega of the medicine department demonstrates the regrowth of chondrocytes cultures through the biostimulation with the Fisioline Superpulsed Laser. The sperimentation will be published on the next number of the prestigious international magazine, in spanish language, Mapre Medicina. |
The Superpulsed Fisioline laser at the next edition of the Master of Tennis in Madrid. |
Installed also in IRAN the Superpulsed Fisioline lasers. |
EXPOSANITÀ
16th International Healthcare Exhibition
Bologna Fair District 28-31/05/2008
PAD. 22 – STAND B27
|
